Elevance Health, Inc. (LON: 0HG8)
London
· Delayed Price · Currency is GBP · Price in USD
369.90
+3.01 (0.82%)
Dec 23, 2024, 7:14 PM BST
Elevance Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
Net Income | 6,418 | 5,987 | 5,894 | 6,158 | 4,572 | 4,807 | Upgrade
|
Depreciation & Amortization | 734 | 1,060 | 1,076 | 817 | 742 | 683 | Upgrade
|
Other Amortization | 685 | 685 | 599 | 485 | 412 | 450 | Upgrade
|
Gain (Loss) on Sale of Assets | -201 | - | - | - | - | - | Upgrade
|
Stock-Based Compensation | 292 | 289 | 264 | 255 | 283 | 294 | Upgrade
|
Change in Accounts Receivable | -1,525 | -1,762 | -2,510 | -2,138 | -256 | -1,053 | Upgrade
|
Change in Accounts Payable | 851 | 1,640 | 824 | 719 | 1,978 | -445 | Upgrade
|
Change in Unearned Revenue | -2,538 | 290 | -42 | -113 | 202 | 115 | Upgrade
|
Change in Income Taxes | -129 | -103 | -338 | 140 | 72 | -325 | Upgrade
|
Change in Insurance Reserves / Liabilities | -1,998 | 147 | 2,411 | 2,523 | 3,528 | 1,826 | Upgrade
|
Change in Other Net Operating Assets | -718 | -747 | 78 | -8 | -270 | -212 | Upgrade
|
Other Operating Activities | 179 | 96 | 429 | 15 | -722 | 14 | Upgrade
|
Operating Cash Flow | 2,131 | 8,061 | 8,399 | 8,364 | 10,688 | 6,061 | Upgrade
|
Operating Cash Flow Growth | -77.60% | -4.02% | 0.42% | -21.74% | 76.34% | 58.37% | Upgrade
|
Capital Expenditures | -1,260 | -1,296 | -1,152 | -1,087 | -1,021 | -1,077 | Upgrade
|
Cash Acquisitions | -1,106 | -1,552 | -649 | -3,476 | -1,976 | - | Upgrade
|
Investment in Securities | -2,338 | -2,700 | -2,338 | -4,056 | -3,433 | -1,919 | Upgrade
|
Other Investing Activities | -253 | -24 | -421 | -1,019 | -894 | 204 | Upgrade
|
Investing Cash Flow | -4,558 | -5,572 | -4,560 | -9,638 | -7,324 | -2,792 | Upgrade
|
Short-Term Debt Issued | - | 339 | 2,600 | 2,331 | 2,305 | 7,590 | Upgrade
|
Long-Term Debt Issued | - | 2,574 | 3,071 | 3,462 | 2,484 | 2,473 | Upgrade
|
Total Debt Issued | 3,287 | 2,913 | 5,671 | 5,793 | 4,789 | 10,063 | Upgrade
|
Total Debt Repaid | -548 | -2,251 | -3,574 | -2,494 | -3,752 | -9,709 | Upgrade
|
Net Debt Issued (Repaid) | 2,739 | 662 | 2,097 | 3,299 | 1,037 | 354 | Upgrade
|
Issuance of Common Stock | 245 | 152 | 182 | 203 | 176 | 187 | Upgrade
|
Repurchases of Common Stock | -2,123 | -2,775 | -2,409 | -2,002 | -2,828 | -1,785 | Upgrade
|
Common Dividends Paid | -1,481 | -1,395 | -1,229 | -1,104 | -954 | -818 | Upgrade
|
Other Financing Activities | 11 | 7 | 41 | 27 | 2 | -204 | Upgrade
|
Financing Cash Flow | -609 | -3,349 | -1,318 | 423 | -2,567 | -2,266 | Upgrade
|
Foreign Exchange Rate Adjustments | 3 | -1 | -14 | -10 | 7 | - | Upgrade
|
Net Cash Flow | -3,053 | -861 | 2,507 | -861 | 804 | 1,003 | Upgrade
|
Free Cash Flow | 871 | 6,765 | 7,247 | 7,277 | 9,667 | 4,984 | Upgrade
|
Free Cash Flow Growth | -89.44% | -6.65% | -0.41% | -24.72% | 93.96% | 90.30% | Upgrade
|
Free Cash Flow Margin | 0.50% | 3.95% | 4.63% | 5.25% | 7.93% | 4.78% | Upgrade
|
Free Cash Flow Per Share | 3.72 | 28.50 | 29.85 | 29.49 | 38.01 | 19.15 | Upgrade
|
Cash Interest Paid | 1,032 | 1,032 | 878 | 822 | 794 | 755 | Upgrade
|
Cash Income Tax Paid | 1,936 | 1,936 | 1,594 | 1,299 | 1,790 | 1,403 | Upgrade
|
Levered Free Cash Flow | -1,112 | 3,005 | 8,445 | 3,614 | 6,741 | 2,092 | Upgrade
|
Unlevered Free Cash Flow | -422.25 | 3,649 | 8,980 | 4,115 | 7,232 | 2,558 | Upgrade
|
Change in Net Working Capital | 7,507 | 3,270 | -2,884 | 1,997 | -1,653 | 2,000 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.